Company
Sibylla Biotech
Sibylla is a preclinical stage company focused on developing small molecule degraders with a novel Mechanism of Action to find new therapeutics for unmet medical needs.
Also known as Sibylla Biotech S.p.A.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Verona, Italy
- Customers
- pharmaceutical companies via drug discovery collaboration
- Legal name
- Sibylla Biotech S.p.A.
- sibyllabiotech.it (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 18 September 2026
About
Our platform is powered by computer simulations and AI methods, which enables the discovery and development of compounds that induce the degradation of a target protein by interfering with its folding pathway.
Funding snapshot
- Latest round
- Series A2022-10-04
Funding rounds
- Series A
- 2022-10-04
Products
- Other
- PPI-FIT
Loading relationship preview